Skip to main content
AA

Ageless Advisors

Ageless Advisors, Inc. is developing an AI chatbot that provides regulatory compliance consulting specifically for early-stage medical device startups, focusing on FDA Pre-Market Approvals and 510K submissions. By utilizing real-time regulatory updates and human-reviewed outputs, the platform reduces consulting costs while ensuring accurate guidance for navigating complex compliance requirements.

Toronto, CanadaFounded 2024410+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Early-stage medical device startups face complex and costly regulatory compliance requirements, particularly with FDA Pre-Market Approvals and 510K submissions. Navigating these processes often requires expensive consultants, creating a barrier to entry and slowing down innovation.

Solution

Ageless Advisors offers an AI-powered regulatory compliance platform designed to streamline FDA submissions for medical device, SiMD, and SaMD companies. The platform analyzes company information to provide tailored strategies and guidance for Pre-Market Approvals and 510Ks. By integrating real-time regulatory updates and human-reviewed outputs, the system ensures accurate and up-to-date advice, reducing reliance on traditional consultants and lowering compliance costs. The platform also assists in identifying predicate devices and preparing for FDA meetings.

Target Audience

The primary target audience consists of early-stage medical device, Software in a Medical Device (SiMD), and Software as a Medical Device (SaMD) startups seeking to navigate FDA Pre-Market Approvals and 510K submissions efficiently and affordably.

Features

  • AI-driven analysis of company data to determine specific regulatory requirements
  • Generation of predicate device references to expedite the submission process
  • Preparation for FDA meetings, including pre-meeting question generation
  • Real-time integration of regulatory policy updates to ensure continuous compliance
  • Human review of all chatbot outputs by regulatory professionals for accuracy
  • Customizable payment plans tailored for startups
  • Support for medical device, SiMD, and SaMD designations
This profile is AI-generated and may contain inaccuracies.